Stem cell characteristics of early colon cancer tissue and their relationship with cell proliferation and invasion
暂无分享,去创建一个
[1] Zaozao Wang,et al. Comparison of EpCAMhighCD44+ cancer stem cells with EpCAMhighCD44− tumor cells in colon cancer by single-cell sequencing , 2018, Cancer biology & therapy.
[2] A. Kazlauskas,et al. Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines , 2018, BMC Cancer.
[3] Camille Stephan-Otto Attolini,et al. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis , 2018, Nature.
[4] T. Itinteang,et al. Characterization of Cancer Stem Cells in Colon Adenocarcinoma Metastasis to the Liver , 2018, Front. Surg..
[5] Alyssa J Miller,et al. Identification, isolation and characterization of human LGR5-positive colon adenoma cells , 2017, Development.
[6] L. Spelt,et al. The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases. , 2018, Anticancer research.
[7] A. Carnero,et al. NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP , 2017, Clinical Cancer Research.
[8] P. Wierzbicki,et al. FasR and FasL in colorectal cancer. , 2017, International journal of oncology.
[9] Ashish S. Bodhade,et al. Cancer stem cells: An insight , 2017, Journal of oral and maxillofacial pathology : JOMFP.
[10] Hui Peng,et al. An epithelial-to-mesenchymal transition-inducing potential of granulocyte macrophage colony-stimulating factor in colon cancer , 2017, Scientific Reports.
[11] Joon Sang Lee,et al. Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers , 2017, Oncogene.
[12] L. Ellis,et al. Endothelial cells activate the cancer stem cell‐associated NANOGP8 pathway in colorectal cancer cells in a paracrine fashion , 2017, Molecular oncology.
[13] A. Berghold,et al. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients. , 2017, Anticancer research.
[14] Chengwu Tang,et al. Blocking hepatic metastases of colon cancer cells using an shRNA against Rac1 delivered by activatable cell-penetrating peptide , 2016, Oncotarget.
[15] Jennifer T. Fox,et al. Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models* , 2016, The Journal of Biological Chemistry.
[16] M. Redondo,et al. Colorectal cancer health services research study protocol: the CCR-CARESS observational prospective cohort project , 2016, BMC Cancer.
[17] Limei Liu,et al. IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial‐Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer , 2016, Stem cells.
[18] F. Sinicrope,et al. The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism* , 2015, The Journal of Biological Chemistry.
[19] Yaoping Li,et al. Overexpressed GRP78 affects EMT and cell-matrix adhesion via autocrine TGF-β/Smad2/3 signaling. , 2015, The international journal of biochemistry & cell biology.
[20] M. Zhong,et al. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients. , 2015, International journal of clinical and experimental pathology.
[21] J. Lancaster,et al. BAD-mediated apoptotic pathway is associated with human cancer development , 2015, International journal of molecular medicine.
[22] D. Iliopoulos,et al. The neurotensin-HIF-1α-VEGFα axis orchestrates hypoxia, colonic inflammation, and intestinal angiogenesis. , 2014, The American journal of pathology.
[23] Yang Han,et al. Increased expression of TBX2 is a novel independent prognostic biomarker of a worse outcome in colorectal cancer patients after curative surgery and a potential therapeutic target , 2013, Medical Oncology.